Treatment with curative intent of stage III non-small cell lung cancer patients of 75 years: A prospective population-based study

European Journal of Cancer

Volumn 47, Issue 18, 2011, Pages 2691-2697

  Wanders, Rinus ^a   Steevens, Jessie ^b   Botterweck, Anita ^a   Dingemans, Anne Marie C ^c   Reymen, Bart ^a   Baardwijk, Angela Van ^a   Borger, Jacques ^a   Bootsma, Gerben ^d   Pitz, Cordula ^e   Lunde, Ragnar ^f   Geraedts, Wiel ^d   Lambin, Philippe ^a   De Ruysscher, Dirk ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Location Maastricht ^*  (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Sittard Geleen Heerlen   (Netherlands)

^e LAURENTIUS HOSPITAL   (Netherlands)

^f St Jansgasthuis ^*  (Netherlands)

Author keywords

Chemotherapy; Combined modality treatment; Elderly; Non small cell lung cancer; Radiotherapy; Stage III; Survival

Indexed keywords

CISPLATIN; GEMCITABINE; NAVELBINE;

AGED; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CHEMORADIOTHERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; INTENTION TO TREAT ANALYSIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NETHERLANDS; OVERALL SURVIVAL; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; REVIEW; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COMORBIDITY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; PALLIATIVE CARE; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 82255186389     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.06.023     Document Type: Article

References (39)

1. H.E. Karim-Kos, E. de Vries, and I. Soerjomataram Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s Eur J Cancer 44 2008 1345 1389
2. T.K. Owonikoko, C.C. Ragin, and C.P. Belani Lung cancer in elderly patients: an analysis of the Surveillance, Epidemiology, and End Results Database J Clin Oncol 25 2007 5570 5577
3. C. Wen, and T. Dehnel China wrestles with lung cancer Lancet Oncol 12 2011 15
4. D. De Ruysscher, A. Botterweck, and M. Dirx Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study Ann Oncol 20 2009 98 102
5. J.M. de Rijke, L.J. Schouten, and G.P. ten Velde Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based study Lung Cancer 46 2004 233 245 (Pubitemid 39334825)
6. A. Aupérin, C. Le Péchoux, and E. Rolland Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer J Clin Oncol 28 2010 2181 2190
7. K.S. Albain, R.S. Swann, and V.W. Rusch Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial Lancet 374 2009 379 386
8. S.E. Schild, P.J. Stella, and S.M. Geyer The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly J Clin Oncol 21 2003 3201 3206 (Pubitemid 46606250)
9. C.J. Langer, C. Hsu, and W.J. Curran Elderly patients with locally advanced non-small cell lung cancer (LA NSCLC) benefit from combined modality therapy, secondary analysis of Radiation Therapy Oncology Group (RTOG) 94-10 Proc Am Soc Clin Oncol 21 2002 299a (Abstract 1193)
10. B. Jeremic, Y. Shibamoto, and B. Milicic A phase II study of concurrent accelerated hyperfractionated radiotherapy and carboplatin/oral etoposide for elderly patients with stage III non-small-cell lung cancer Int J Radiat Oncol Biol Phys 44 1999 343 348 (Pubitemid 29205032)
11. S. Atagi, M. Kawahara, and T. Tamura Standard thoracic radiotherapy with or without concurrent daily low-dose carboplatin in elderly patients with locally advanced non-small cell lung cancer: a phase III trial of the Japan Clinical Oncology Group (JCOG9812) Jpn J Clin Oncol 35 2005 195 201 (Pubitemid 40796853)
12. S.E. Schild, S.J. Mandrekar, and A. Jatoi The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer Cancer 110 2007 363 368 (Pubitemid 47121897)
13. C.M. Rocha Lima, J.E. Herndon 2nd, and M. Kosty Therapy choices among older patients with lung carcinoma: an evaluation of two trials of the Cancer and Leukemia Group B Cancer 94 2002 181 187 (Pubitemid 34049057)
14. A.G. Pallis, C. Gridelli, and J.P. van Meerbeeck EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population Ann Oncol 21 2010 692 706
15. E.A. Chrischilles, J.F. Pendergast, and K.L. Kahn Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer J Clin Oncol 28 2010 620 627
16. L.F. Hutchins, J.M. Unger, and J.J. Crowley Underrepresentation of patients 65 years of age older in cancer-treatment trials N Engl J Med 341 1999 2061 2067 (Pubitemid 30035956)
17. R.R. Jennens, and G.G. Giles Fox RM: Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials Intern Med J 36 2006 216 220
18. S. Firat, R.W. Byhardt, and E. Gore The effects of comorbidity and age on RTOG study enrollment in Stage III non-small cell lung cancer patients who are eligible for RTOG studies Int J Radiat Oncol Biol Phys 78 2010 1394 1399
19. S. Firat, A. Pleister, R.W. Byhardt, and E. Gore Age is independent of comorbidity influencing patient selection for combined modality therapy for treatment of stage III nonsmall cell lung cancer (NSCLC) Am J Clin Oncol 29 2006 252 257 (Pubitemid 44270933)
20. World Health Organization. International Classification of Diseases for Oncology (ICD-O-3) 3rd ed. Geneva; 2000.
21. L.H. Sobin Wittekind Ch, editors. International Union Against Cancer (UICC). TNM Classification of Malignant Tumours 6th ed. 2002 Wiley-Liss New York
22. L.J. Schouten, P. Hoppener, and P.A. van den Brandt Completeness of cancer registration in Limburg, The Netherlands Int J Epidemiol 22 1993 369 376 (Pubitemid 23208931)
23. M. Charlson, T.P. Szatrowski, and J. Peterson Validation of a combined comorbidity index J Clin Epidemiol 47 1994 1245 1251 (Pubitemid 24361532)
24. P. Therasse, S. Arbuck, and E. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 2000 205 216 (Pubitemid 30099779)
25. ICRU Report 50. Prescribing, Recording, and reporting Photon Beam Therapy. International Commission on Radiation Units and Measurements, 1993.
26. D. De Ruysscher, S. Wanders, and E. van Haren Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study Int J Radiat Oncol Biol Phys 62 2005 988 994 (Pubitemid 40884408)
27. A. van Baardwijk, S. Wanders, and L. Boersma Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer J Clin Oncol 28 2010 1380 1386
28. C. Pöttgen, W.E. Eberhardt, and T. Gauler Intensified high-dose chemoradiotherapy with induction chemotherapy in patients with locally advanced non-small-cell lung cancer-safety and toxicity results within a prospective trial Int J Radiat Oncol Biol Phys 76 2010 809 815
29. A.G. Pallis, C. Fortpied, and U. Wedding EORTC elderly task force position paper: approach to the older cancer patient Eur J Cancer 46 2010 1502 1513
30. S.K. Vinod, M.A. Sidhom, and G.S. Gabriel Why do some lung cancer patients receive no anticancer treatment? J Thorac Oncol 5 2010 1025 1032
31. E.D. Crawford, R. Grubb 3rd, and A. Black Comorbidity and mortality results from a randomized prostate cancer screening trial J Clin Oncol 29 2011 355 361
32. Dehing-Oberije C, Aerts H, Yu S, et al. Development and validation of a prognostic model using blood biomarker information for prediction of survival of non-small-cell lung cancer patients treated with combined chemotherapy and radiation or radiotherapy alone (NCT00181519, NCT00573040, and NCT00572325). Int J Radiat Oncol Biol Phys 2010 [Epub ahead of print].
33. C.Q. Zhu, K. Ding, and D. Strumpf Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer J Clin Oncol 28 2010 4417 4424
34. Y.T. Huang, R.S. Heist, and L.R. Chirieac Genome-wide analysis of survival in early-stage non-small-cell lung cancer J Clin Oncol 27 2009 2660 2667
35. A. van Baardwijk, S. Wanders, and L. Boersma Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer J Clin Oncol 28 2010 1380 1386
36. P. Lambin, S.F. Petit, and H.J. Aerts The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancer Radiother Oncol 96 2010 145 152
37. T.R. Asmis, K. Ding, and L. Seymour National Cancer Institute of Canada Clinical Trials Group. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials J Clin Oncol 26 2008 54 59
38. W.L. Read, R.M. Tierney, and N.C. Page Differential prognostic impact of comorbidity J Clin Oncol 22 2004 3099 3103 (Pubitemid 41103722)
39. L.E. Coate, C. Massey, and A. Hope Treatment of the elderly when cure is the goal: the influence of age on treatment selection and efficacy for stage III non-small cell lung cancer J Thorac Oncol 6 2011 537 544